IMI – Clinical Management Guidelines Supplementary Digital Content

The landmark International Myopia Institute (IMI) White paper reports were published on 28 February 2019. As lead author on the Clinical Management Guidelines paper, I was thrilled to see the work of my 13 co-authors and I shared with a keen clinician audience worldwide. It was drawn to my attention, though, that the promised Supplementary Digital Content had not been …

Read MoreIMI – Clinical Management Guidelines Supplementary Digital Content

Axial length measurement – a clinical necessity?

Most eye care practitioners don’t routinely measure axial length in clinical practice, mainly due to lack of access to the instrumentation and its expense. This is not the only reason, though, that axial length (AXL) measurement is a bit of a problematic measure for gauging myopia management success in a clinical setting. When I was leading the authorship of the …

Read MoreAxial length measurement – a clinical necessity?

Eight Myopia Mysteries (plus eight more!)

This open-access continuing education article I authored was published in Australian professional journal Mivision in December 2018. It describes that while there’s a lot we know about myopia control – the imperative to reduce lifelong risk of vision impairment; that numerous options are available; and that the sooner we start the better – it is imperative for the clinician to …

Read MoreEight Myopia Mysteries (plus eight more!)

Atropine – wonder or weak treatment?

Atropine has been the apparent hero of myopia management since the 2006 publication of the ATOM (atropine for the treatment of childhood myopia) study, which showed an 80% refractive and 100% axial length myopia controlling effect with 1% atropine compared to placebo.1 The significant side effects of mydriasis and cycloplegia, though, made it less than tolerable as a first line …

Read MoreAtropine – wonder or weak treatment?

Latest research: International Myopia Conference 2017, Part 1

The sixteenth, biennial International Myopia Conference (IMC) brought together over 350 myopia researchers from more than a dozen countries to drizzly, chilly Birmingham in September 2017, where the latest research was presented in 45 lectures and more than 150 scientific posters over four days. The session topics covered prevalence, progression and risk factors of myopia, mechanisms such as light exposure …

Read MoreLatest research: International Myopia Conference 2017, Part 1

Latest research: International Myopia Conference 2017, Part 2

More of the latest from the sixteenth biennial International Myopia Conference (IMC) is below – read here for Part 1. Three more fascinating areas and/or pieces of research presented at IMC, and some bonus material, are below. A more detailed write up, published in Australian industry journal Mivision, can be accessed from the link, which includes relevant references. IMC #4 – …

Read MoreLatest research: International Myopia Conference 2017, Part 2

Myopia control – science or luck?

Mounting evidence from clinical studies published in the last 10 years demonstrate the efficacy of orthokeratology (OrthoK) in slowing myopic progression and controlling axial length increases in children.1,2 OrthoK has also been shown to be a safe and efficacious means of correcting refractive error.3 But, even with our best intention to slow myopic progression with OrthoK, none of us is truly …

Read MoreMyopia control – science or luck?